| ABIRATERONE |
Zytiga® |
Janssen-Cilag Pty Ltd |
|
Jul 2012 |
|
| AZTREONAM |
Cayston® |
Gilead Sciences Pty Limited |
|
Jul 2012 |
|
| BOCEPREVIR |
Victrelis® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Jul 2012 |
|
| BOTULINUM TOXIN TYPE A PURIFIED NEUROTOXIN COMPLEX |
Botox® |
Allergan Australia Pty Ltd |
|
Jul 2012 |
|
| BOTULINUM TOXIN TYPE A PURIFIED NEUROTOXIN COMPLEX |
Botox® |
Allergan Australia Pty Ltd |
|
Jul 2012 |
|
| DABIGATRAN ETEXILATE |
Pradaxa® |
Boehringer Ingelheim Pty Ltd |
|
Jul 2012 |
|
| DORZOLAMIDE HYDROCHLORIDE WITH TIMOLOL MALEATE |
Cosopt® |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Jul 2012 |
|
| ERLOTINIB |
Tarceva® |
Roche Products Pty Ltd |
|
Jul 2012 |
|
| EZETIMIBE AND ATORVASTATIN |
Atozet® Composite Pack |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
Jul 2012 |
|
| IVABRADINE |
Coralan® |
Servier Laboratories (Aust.) Pty. Ltd. |
|
Jul 2012 |
|
| LINAGLIPTIN |
Trajenta® |
Boehringer Ingelheim Pty Ltd |
|
Jul 2012 |
|
| METHYLPHENIDATE HYDROCHLORIDE |
Concerta® |
Janssen-Cilag Pty Ltd |
|
Jul 2012 |
|
| MYCOPHENOLATE SODIUM |
Myfortic® |
Novartis Pharmaceuticals Australia Pty Limited |
|
Jul 2012 |
|
| PLERIXAFOR |
Mozobil® |
sanofi-aventis Australia Pty Ltd |
|
Jul 2012 |
|
| PRUCALOPRIDE |
Resotrans® |
Janssen-Cilag Pty Ltd |
|
Jul 2012 |
|
| RIFAXIMIN |
Xifaxan® |
Norgine Pty. Ltd. |
|
Jul 2012 |
|
| SAPROPTERIN |
Kuvan® |
Merck Serono Pty Ltd |
|
Jul 2012 |
|
| SAXAGLIPTIN |
Onglyza® |
Bristol-Myers Squibb Australia Pty Ltd |
|
Jul 2012 |
|
| STATIN THERAPIES REVIEW |
|
|
|
Jul 2012 |
|
| STRONTIUM RANELATE |
Protos® |
Servier Laboratories (Aust.) Pty. Ltd. |
|
Jul 2012 |
|
| SUNITINIB MALATE |
Sutent® |
Pfizer Australia Pty Ltd |
|
Jul 2012 |
|
| TAPENTADOL |
Palexia SR® |
CSL Limited |
|
Jul 2012 |
|
| TELAPREVIR |
Incivo® |
Janssen-Cilag Pty Ltd |
|
Jul 2012 |
|
| TRASTUZUMAB |
Herceptin® |
Roche Products Pty Ltd |
|
Jul 2012 |
|
| VEMURAFENIB |
Zelboraf® |
Roche Products Pty Ltd |
|
Jul 2012 |
|